IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IDEXX Laboratories, Inc. (IDXX) P/B ratio

As of 25 September 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/B ratio of 25.4×. Over the past ten years it has ranged from 0.0× (March 2019) to 859× (August 2015); the current reading is higher than 35% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 33.9× 58.59%
FY2024 21.4× (30.26%)
FY2023 30.6× (45.05%)
FY2022 55.8× (31.40%)
FY2021 81.3× 20.61%
FY2020 67.4× (46.69%)
FY2019 126× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period P/B ratio Change
Jun 2026 25.8× (10.38%)
Mar 2026 28.8× (15.15%)
Dec 2025 33.9× 3.40%
Sep 2025 32.8× 10.87%
42 more quarters

Against its own ten years

Low 0.0× High 859×
Ten-year median 34.6×
Current reading's percentile 35

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
WAT Waters Corporation compare 2.8×
DGX Quest Diagnostics Incorporated compare 3.4×
A Agilent Technologies, Inc. compare 6.6×
IQV IQVIA Holdings Inc. compare 7.1×
ILMN Illumina, Inc. compare 14.5×
IDXX IDEXX Laboratories, Inc. 25.4×
NTRA Natera, Inc. compare 32.5×
MTD Mettler-Toledo International, Inc. compare 2,372×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on IDXX